Daily Dose - Mar 27th, 2026
Daily Dose |
View online
March 27, 2026
Celltrion pledges $800M to expand manufacturing capacity at South Korea headquarters
The manufacturer of biosimilars will construct Plants 4 and 5 at its Songdo campus in Incheon, with a combined capacity of 180,000 liters.
Read More
Cytiva to support Yoshindo biosimilar drug substance production in Japan
The Toyama facility is expected to support monoclonal antibody biosimilar drug substance manufacturing using Cytiva’s standardized, modular bioprocessing technology.
Read More
Lonza launches media development lab to support GMP scale-up in Singapore
The service uses a structured approach to identify and optimize cell culture media formulations early in development, according to the company.
Read More